Recently, it has become a standard treatment to use androgen receptor signaling inhibitors (ARSIs) or/and docetaxel in addition to medical or surgical castration from the initial treatment, according to the risk of prostate cancer [3]. This evidence concerns the gene AR and prostate carcinoma.